| Latest Immucor News Headlines | | Date | Time | Source | | | 01/19/2009 | 3:00PM | PRNUS | Immucor Announces New Vice President, Operations
NORCROSS, Ga., Jan. 19 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Michael Pred has joined the Company as Vice President, Operations, responsible for overseeing all U.S. manufacturing... More...>> |
| 01/14/2009 | 6:20PM | PRNUS | Standard & Poor's Announces Changes to U.S. Indices
NEW YORK, Jan. 14 /PRNewswire/ -- Standard & Poor's will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:
-- S&P SmallCap 600 constituent Landstar System Inc. (NASDAQ:LSTR) will
replace Pacific Sunwear of California Inc. (NASDAQ:PSUN) in the S&P
MidCap 400, and American... More...>> |
| 01/07/2009 | 4:01PM | PRNUS | Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
NORCROSS, Ga., Jan. 7 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal second quarter ended November 30, 2008.
Financial Highlights
-- Revenue for the fiscal second... More...>> |
| 10/01/2008 | 4:01PM | PRNUS | Immucor Announces Record Fiscal First Quarter Results
NORCROSS, Ga., Oct. 1 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal first quarter ended August 31, 2008. Our first quarter 2009 results include the results of... More...>> |
| 06/04/2008 | 4:01PM | PRNUS | Immucor Announces Fiscal Year 2009 Revenue and Earnings Guidance
NORCROSS, Ga., June 4 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced revenue and earnings guidance for the fiscal year ending May 31, 2009.
For fiscal year 2009:
-- The company expects revenues... More...>> |
| 04/17/2008 | 4:30PM | PRNUS | Immucor CEO's Italian Trial Moves Toward Second Phase
NORCROSS, Ga., April 17 /PRNewswire-FirstCall/ -- Immucor, Inc., (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today the first level of the Italian court case against CEO Gioacchino "Nino" De Chirico has concluded and will now move to the... More...>> |
| 04/01/2008 | 4:01PM | PRNUS | Immucor Announces Record Fiscal Third Quarter Results
NORCROSS, Ga., April 1, 2008 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal third quarter ended February 29, 2008.
Revenue for the fiscal third quarter was $67.0... More...>> |
| 01/29/2008 | 3:19PM | PRNUS | Immucor, Inc. Adds Director to Board
NORCROSS, Ga., Jan. 29 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Ronny B. Lancaster has agreed to join Immucor's Board of Directors effective February 1, 2008. Mr. Lancaster currently... More...>> |
| 01/07/2008 | 4:01PM | PRNUS | Immucor Announces Fiscal Second Quarter Results
NORCROSS, Ga., Jan. 7 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal second quarter ended November 30, 2007.
Revenue for the fiscal second quarter was $61.9 million... More...>> |
| 01/07/2008 | 10:27AM | PRNUS | Immucor Announces Update to Second Quarter Conference Call Number
NORCROSS, Ga., Jan. 7 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced an update to the telephone conference call number for its second quarter earnings call to be held on Tuesday, January 8, 2008... More...>> |
| 01/02/2008 | 10:03AM | PRNUS | Immucor Schedules Second Quarter Earnings Release and Conference Call
NORCROSS, Ga., Jan. 2 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its second quarter earnings on Monday, January 7, 2008, after the close of regular trading hours... More...>> |
| 11/20/2007 | 4:14PM | PRNUS | Immucor, Inc. Appoints New Chief Financial Officer
NORCROSS, Ga., Nov. 20 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Richard A. Flynt has agreed to join Immucor as Vice President and Chief Financial Officer effective December 10, 2007... More...>> |
| 10/04/2007 | 9:31AM | PRNUS | Seven Summits Research Releases Alerts on GE, SHLD, MAR, FO, and BLUD
CHICAGO, Oct. 4 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.
Seven Summits Strategic Investments' PriceWatch Alerts are available at
http://www.iotogo.com/s/100407B (Note: You may have to copy this link into your browser then press the [ENTER] key.)
Today's PriceWatch Alerts cover... More...>> |
| 10/03/2007 | 4:08PM | PRNUS | Immucor Announces Record Fiscal First Quarter Revenues
NORCROSS, Ga., Oct. 3 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal first quarter ended August 31, 2007.
Revenue for the fiscal first quarter was a record $63.6... More...>> |
| 09/28/2007 | 9:01AM | PRNUS | Immucor Settles SEC Investigation
Court Approves Class Action Settlement
NORCROSS, Ga., Sept. 28 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), the global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that the Securities and Exchange Commission (SEC) has agreed to a complete settlement... More...>> |
| 09/28/2007 | 9:00AM | PRNUS | Immucor Schedules First Quarter Earnings Release and Conference Call
NORCROSS, Ga., Sept. 28 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its first quarter earnings on Wednesday, October 3, 2007, after the close of regular trading hours... More...>> |
| 08/17/2007 | 3:37PM | PRNUS | Immucor Announces Supply Agreement with the American Red Cross
NORCROSS, Ga., Aug. 17 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that it has signed a supply agreement with the American Red Cross for 19 Galileo systems for its five U.S. National Testing... More...>> |
| 07/25/2007 | 4:01PM | PRNUS | Immucor Announces Record Fiscal Fourth Quarter and Record Year End Results
NORCROSS, Ga., July 25 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal fourth quarter and year ended May 31, 2007.
Revenue for the fiscal fourth quarter was a record... More...>> |
| 07/20/2007 | 9:30AM | PRNUS | Immucor Schedules Fourth Quarter Earnings Release and Conference Call
NORCROSS, Ga., July 20 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its fourth quarter and year end earnings on Wednesday, July 25, 2007, after the close of regular... More...>> |
| 06/19/2007 | 10:00AM | PRNUS | Immucor's Echo Cleared by FDA for Marketing in U.S.
Registered as CE Marked for Distribution in Europe
NORCROSS, Ga., June 19 /PRNewswire-FirstCall/ -- Immucor, Inc. (NASDAQ:BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that the U.S. Food and Drug Administration has cleared Galileo Echo(TM... More...>> |
|